Asahi Kasei Pharma Denmark A/S
CVR 40948074 · Public limited company (A/S) · Active · Low risk
Asahi Kasei Pharma Denmark A/S is a Public limited company (A/S), founded on , based in Nordhavn. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.0 times the average for Danish companies. 6 annual reports have been published, of which 3 more than six months after the end of the financial year. The latest annual report (31 Mar 2026) shows equity of DKK 1.0bn and a net result of DKK 25.8m. CEO: Daisuke Matsuo.
Bankruptcy risk for Asahi Kasei Pharma Denmark A/S
0.0 × the average (1.41%) · higher risk than 27% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 40948074
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (6 years)
- Address
- c/o Bech-Bruun, Gdanskgade 18
2150 Nordhavn - Municipality
- København
- Industry
- Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater - Share capital
- DKK 901.6m
- Auditor
- PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 3 of 6 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 99.8% |
| Current ratio | 47,254% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 276 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2026 | 2025 | 2024 |
|---|---|---|---|
| Gross profit | DKK -793k | DKK -639k | DKK -758k |
| Net profit | DKK 25.8m | DKK 26.1m | DKK 25.5m |
| Equity | DKK 1.0bn | DKK 977.5m | DKK 951.4m |
| Total assets | DKK 1.0bn | DKK 983.0m | DKK 957.1m |
| Cash | DKK 2.9m | DKK 2.3m | – |
| Short-term debt | DKK 2.1m | DKK 5.5m | – |
| Tax owed | DKK 277k | DKK 187k | – |
| Avg. employees | 0 | 0 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Apr 2025 – 31 Mar 2026 | 196 | Late | |
| 1 Apr 2024 – 31 Mar 2025 | 192 | Late | |
| 1 Apr 2023 – 31 Mar 2024 | 218 | Late | |
| 1 Apr 2022 – 31 Mar 2023 | 174 | ||
| 1 Apr 2021 – 31 Mar 2022 | 154 | ||
| 21 Nov 2019 – 31 Mar 2021 | 124 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Daisuke Matsuo | Current | |
| Board | Masaya Etoh | Current | |
| Board | Daisuke Matsuo | Current | |
| Board | Kenro Yuzaki | Current | |
| Board | Matthew Ryan Dumont | ||
| Owner (100%) | Asahi Kasei Corporation | Current | |
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | Current | |
| Auditor | DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Founder | Jacob Hjortshøj | Current |
Address history (2 moves)
| c/o Bech-Bruun, Gdanskgade 18, 2150 Nordhavn | |
| c/o Bech-Bruun, Gdanskgade 18, 2150 Nordhavn | |
| c/o Bech-Bruun, Langelinie Allé 35, 2100 København Ø |
Former names
| Asahi Kasei Pharma Denmark A/S | – now |
| River Forest A/S | – |
Other companies at the same address
- ADVOKATANPARTSSELSKABET J. PETERSEN Active
- AK Valhalla Denmark Bidco ApS Active
- AKTIESELSKABET CASINO EJENDOMSSELSKAB Active
- ASEN 2 ApS Active
- ASEN 3 ApS Active
- ASEN 4 ApS Active
- ATKL Brasiliana GP ApS Active
- Aktieselskabet af 27.04.1999 Opløst
- America Europe Connect 2 Denmark ApS Active
- Anpartsselskabet af 20. juni 2023 Active
- Aqua Comms Denmark ApS Active
- Asen 1 ApS Opløst
- Asen 5 ApS Active
- Asen 6 ApS Active
- Asen 7 ApS Active
- Asen 8 ApS Active
- Asen 9 ApS Active
- Asen Holding 1 ApS Active
- Asen Holding 2 ApS Active
- Asen Holding 3 ApS Active
- Asen Holding 5 ApS Active
- Asen Holding 6 ApS Active
- Atreides Caseri Denmark ApS Active
- BGM-CO GP ApS Active
- BMF INVESTMENT CORPORATION ApS Opløst
Similar companies in København
- H. LUNDBECK A/S Valby
- GUNNAR KJEMS ApS København K
- Tetrapharm Therapeutics ApS København S
- Tetrapharm Bioengineering ApS København S
- Luvalis Pharma ApS Vanløse
- NeuroVersis Therapeutics ApS København K
- QuantumCell ApS København K
- Vautia Therapeutics ApS København K
- Corxel Pharmaceuticals Denmark ApS København V
- Dispersome IP ApS København Ø
- Maddox Pharma Swiss ApS København S
- Gefjon Pharma ApS København N
Questions and answers about Asahi Kasei Pharma Denmark A/S
Has Asahi Kasei Pharma Denmark A/S gone bankrupt?
No, Asahi Kasei Pharma Denmark A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Asahi Kasei Pharma Denmark A/S?
Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the CEO of Asahi Kasei Pharma Denmark A/S?
Daisuke Matsuo is the CEO of Asahi Kasei Pharma Denmark A/S.
Who is the auditor of Asahi Kasei Pharma Denmark A/S?
Asahi Kasei Pharma Denmark A/S most recently used PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB.
When was Asahi Kasei Pharma Denmark A/S founded?
Asahi Kasei Pharma Denmark A/S was founded on 21 November 2019.
What is the equity of Asahi Kasei Pharma Denmark A/S?
Equity was DKK 1.0bn according to the annual report for the period ending 31 March 2026.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.